ClinConnect ClinConnect Logo
Search / Trial NCT06935097

Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer

Launched by M.D. ANDERSON CANCER CENTER · Apr 11, 2025

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how a Mediterranean diet might help men with prostate cancer who are treated at LBJ Hospital in Harris County, Texas. The Mediterranean diet is rich in fruits, vegetables, whole grains, and healthy fats, and the researchers want to see if following this diet can be beneficial for men who are Hispanic and/or Black/African American and have been diagnosed with localized prostate cancer within the past year or are under active surveillance.

To join the study, participants need to have a confirmed diagnosis of prostate cancer and be patients at LBJ Hospital. They should be between the ages of 65 and 74, and they must be willing to try changing their diet to follow the Mediterranean guidelines. Participants will keep track of their food intake and take part in study activities, but they should not have any food allergies that would prevent them from following the diet. This trial is not yet recruiting participants, but it aims to help improve dietary options and health outcomes for men facing prostate cancer.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Histologically confirmed adenocarcinoma of the prostate that is localized based on metastatic workup ordered by the treating physician (which may include CT scan, bone scan, MRI and/or other imaging). Note that metastatic workup is not required for enrollment.
  • Diagnosis within 12 months prior to enrollment OR
  • Currently managed on active surveillance, with initial biopsy being \<5 years from date of enrollment
  • Self-identified Hispanic and/or Black/African American
  • Patient at LBJ Hospital
  • Exclusion Criteria:
  • Special dietary requirements such that patient is unwilling to attempt dietary change
  • Inability to complete a food record
  • Unwillingness to participate in study activities
  • Inability to keep appointments
  • Food allergy prohibitive of a Mediterranean diet, i.e. nuts allergy

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Patients applied

0 patients applied

Trial Officials

Justin Gregg, MD

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported